Product Code: ETC7053029 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Egypt Pelvic Inflammatory Disease Therapeutics Market Overview |
3.1 Egypt Country Macro Economic Indicators |
3.2 Egypt Pelvic Inflammatory Disease Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Egypt Pelvic Inflammatory Disease Therapeutics Market - Industry Life Cycle |
3.4 Egypt Pelvic Inflammatory Disease Therapeutics Market - Porter's Five Forces |
3.5 Egypt Pelvic Inflammatory Disease Therapeutics Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Egypt Pelvic Inflammatory Disease Therapeutics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Egypt Pelvic Inflammatory Disease Therapeutics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Egypt Pelvic Inflammatory Disease Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increased awareness and education about pelvic inflammatory disease (PID) in Egypt |
4.2.2 Rising prevalence of sexually transmitted infections (STIs) contributing to PID cases |
4.2.3 Growing healthcare infrastructure and access to medical facilities for PID diagnosis and treatment |
4.3 Market Restraints |
4.3.1 Limited public healthcare funding and resources for PID management |
4.3.2 Stigma associated with reproductive health issues leading to underreporting and underdiagnosis of PID |
5 Egypt Pelvic Inflammatory Disease Therapeutics Market Trends |
6 Egypt Pelvic Inflammatory Disease Therapeutics Market, By Types |
6.1 Egypt Pelvic Inflammatory Disease Therapeutics Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Egypt Pelvic Inflammatory Disease Therapeutics Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Egypt Pelvic Inflammatory Disease Therapeutics Market Revenues & Volume, By Tetracycline, 2021- 2031F |
6.1.4 Egypt Pelvic Inflammatory Disease Therapeutics Market Revenues & Volume, By Beta-lactam, 2021- 2031F |
6.1.5 Egypt Pelvic Inflammatory Disease Therapeutics Market Revenues & Volume, By Macrolides, 2021- 2031F |
6.1.6 Egypt Pelvic Inflammatory Disease Therapeutics Market Revenues & Volume, By Nitroimidazoles, 2021- 2031F |
6.1.7 Egypt Pelvic Inflammatory Disease Therapeutics Market Revenues & Volume, By Other Drug Classes, 2021- 2031F |
6.2 Egypt Pelvic Inflammatory Disease Therapeutics Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Egypt Pelvic Inflammatory Disease Therapeutics Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Egypt Pelvic Inflammatory Disease Therapeutics Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.2.4 Egypt Pelvic Inflammatory Disease Therapeutics Market Revenues & Volume, By Other Routes of Administration, 2021- 2031F |
6.3 Egypt Pelvic Inflammatory Disease Therapeutics Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Egypt Pelvic Inflammatory Disease Therapeutics Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Egypt Pelvic Inflammatory Disease Therapeutics Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.4 Egypt Pelvic Inflammatory Disease Therapeutics Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 Egypt Pelvic Inflammatory Disease Therapeutics Market Import-Export Trade Statistics |
7.1 Egypt Pelvic Inflammatory Disease Therapeutics Market Export to Major Countries |
7.2 Egypt Pelvic Inflammatory Disease Therapeutics Market Imports from Major Countries |
8 Egypt Pelvic Inflammatory Disease Therapeutics Market Key Performance Indicators |
8.1 Number of PID awareness campaigns conducted annually |
8.2 Percentage increase in STI screening rates in Egypt |
8.3 Average time from symptom onset to PID diagnosis |
8.4 Adoption rate of evidence-based PID treatment guidelines |
9 Egypt Pelvic Inflammatory Disease Therapeutics Market - Opportunity Assessment |
9.1 Egypt Pelvic Inflammatory Disease Therapeutics Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Egypt Pelvic Inflammatory Disease Therapeutics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Egypt Pelvic Inflammatory Disease Therapeutics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Egypt Pelvic Inflammatory Disease Therapeutics Market - Competitive Landscape |
10.1 Egypt Pelvic Inflammatory Disease Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Egypt Pelvic Inflammatory Disease Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |